7-chloro-1-(4-chlorophenyl)-1-oxoheptane, 97.0%, 5g

(1H-Imidazol-2-yl)boronic acid hydrochloride, 95.0%, 5g

3-(2-Chloroethyl)-2-(2-chloroethylamino)tetrahydro-2H-1,3,2-oxaazaphosphorin 2-oxide, 98%, 1g

2,5-Dichloro-3,4-dinitrothiophene, 97%, 1g

Lead(II) Iodide (99.99%, trace metals basis) [for Perovskite precursor]>98.0%(T)1kg

7-Bromo-1-methyl-3,4-dihydroquinolin-2(1H)-one, 98%, 1g

2-Amino-5-(3-(piperazin-1-yl)phenyl)-N-(pyridin-4-yl)nicotinamide, 98%, 25mg

3-Aminosalicylic acid, 95.0%, 1g

3,4,5-Trifluorobenzoic acid, 98.0%, 10g

[1-(3-Bromo-benzenesulfonyl)-piperidin-4-yl]-methyl-amine hydrochloride, 95.0%, 100mg

(E)-2-CYANO-3-(3,6-DICHLOROPYRIDIN-2-YL)-N-(1-(4-(2-MORPHOLINOETHOXY)PHENYL)BUTYL)ACRYLAMIDE, 95%, 50mg

Syringe filters Millex® Hydrophobic polytetrafluoroethylene (PTFE), 0,45 µm, 13 mm, Millex® FH with extended outlet, 100 Piece(s)

Ethiprole, 98%, 250mg